Headline »

January 31, 2017 – 1:38 pm | 1,757 views

What Works For Anxiety Disorders–Anti-Anxiety Drugs

Short-term use (up to four weeks)
Our rating
Long-term use
Our rating

GAD
 
GAD
 

PTSD and ASD
 
PTSD and ASD
 

Social Phobia
 
Social Phobia
 

Panic Disorder and Agoraphobia

Panic Disorder and Agoraphobia
 

Specific Phobias
 
Specific Phobias
 

OCD
 
OCD
 

WHAT ARE THEY?
Anti-anxiety drugs are used mainly for …

Read the full story »
Antidepressants

Antidepressant Drugs »»» Celexa (citalopram) Luvox (fluvoxamine) Paxil (paroxetine) Prozac (fluoxetine) Zoloft (sertraline)

Antipsychotics

Antipsychotic Drugs »»» Moban Risperdal (risperidone) Seroquel (quetiapine) Stelazine Zyprexa (olanzapine)

Antimanic Agents

Mood Stabalizers »»» Depakene Depakote sprinkles Lamictal (lamatrogine) Lithium (lithium carbonate) Eskalith Lithobid

Antianxiety

Antianxiety Drugs »»» Ativan (lorazepam) BuSpar (buspirone) Klonopin (clonazepam) Valium (diazepam) Xanax (alprazolam)

Anti-Epileptic Drugs

Anti-epileptic drugs (AEDs) are the main form of treatment for people with epilepsy. There are around 26 AEDs used to treat seizures.

Home » Archive by Category

Articles in MAOIs

PARNATE®

November 26, 2016 – 2:40 pm | 244 views

PrPARNATE®
Tranylcypromine Tablets USP
CONSUMER INFORMATION
This leaflet is part III of a three-part “Product Monograph” published for PARNATE®, approved for sale in Canada and is designed specifically for Consumers. This leaflet is a summary and will not …

EMSAM® [EM sam] (selegiline transdermal system)

November 21, 2016 – 9:52 pm | 168 views

EMSAM® [EM sam] (selegiline transdermal system)
MEDICATION GUIDE
Read this Medication Guide carefully before you start using EMSAM and each time you get a refill. There may be new information. This information does not take the place …

NARDIL® TABLETS-Phenelzine

November 6, 2016 – 11:08 am | 209 views

NARDIL® TABLETS-Phenelzine
PACKAGE LEAFLET: INFORMATION FOR THE USER
Read all of this leaflet carefully before you start taking this medicine.

Please keep this leaflet. You may need to read it again.
If you have any further questions, ask your …